ACA
Avoro Capital Advisors’s Taysha Gene Therapies TSHA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.1M | Buy |
21,700,000
+1,700,001
| +9% | +$3.93M | 0.88% | 22 |
|
|
2025
Q1 | $27.8M | Hold |
19,999,999
| – | – | 0.43% | 28 |
|
|
2024
Q4 | $34.6M | Buy |
19,999,999
+1,349,999
| +7% | +$2.34M | 0.49% | 28 |
|
|
2024
Q3 | $37.5M | Hold |
18,650,000
| – | – | 0.55% | 29 |
|
|
2024
Q2 | $41.8M | Hold |
18,650,000
| – | – | 0.56% | 31 |
|
|
2024
Q1 | $53.5M | Buy |
18,650,000
+14,294,445
| +328% | +$41M | 0.62% | 30 |
|
|
2023
Q4 | $7.71M | Buy |
4,355,555
+430,555
| +11% | +$762K | 0.11% | 41 |
|
|
2023
Q3 | $12.4M | Buy |
+3,925,000
| New | +$12.4M | 0.19% | 37 |
|